Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT)
Publication
, Conference
Solanki, AA; Bitting, R; Campbell, D; Carlson, K; Garraway, I; Henry, E; Johnson, M; Jones, J; Koppes, T; Quek, M; Rettig, M; Ritter, TA ...
Published in: Cancer Research
April 25, 2025
Duke Scholars
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 25, 2025
Volume
85
Issue
8_Supplement_2
Start / End Page
CT254 / CT254
Publisher
American Association for Cancer Research (AACR)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Solanki, A. A., Bitting, R., Campbell, D., Carlson, K., Garraway, I., Henry, E., … Nickols, N. G. (2025). Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). In Cancer Research (Vol. 85, pp. CT254–CT254). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2025-ct254
Solanki, Abhishek A., Rhonda Bitting, Dara Campbell, Kimberly Carlson, Isla Garraway, Elizabeth Henry, Michelle Johnson, et al. “Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT).” In Cancer Research, 85:CT254–CT254. American Association for Cancer Research (AACR), 2025. https://doi.org/10.1158/1538-7445.am2025-ct254.
Solanki AA, Bitting R, Campbell D, Carlson K, Garraway I, Henry E, et al. Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). In: Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT254–CT254.
Solanki, Abhishek A., et al. “Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT).” Cancer Research, vol. 85, no. 8_Supplement_2, American Association for Cancer Research (AACR), 2025, pp. CT254–CT254. Crossref, doi:10.1158/1538-7445.am2025-ct254.
Solanki AA, Bitting R, Campbell D, Carlson K, Garraway I, Henry E, Johnson M, Jones J, Koppes T, Quek M, Rettig M, Ritter TA, Robin L, Salama JK, Skipworth A, Zachny E, Zheng K, Nickols NG. Abstract CT254: Veterans Affairs seamless phase II/III randomized trial of standard systemic therapy with or without PET-directed local therapy for oligometastatic prostate cancer (VA STARPORT). Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT254–CT254.
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 25, 2025
Volume
85
Issue
8_Supplement_2
Start / End Page
CT254 / CT254
Publisher
American Association for Cancer Research (AACR)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis